Search by keywords: and/or Search by cancer type: Thoracic-Lung Cancer [5]--Lung Cancer, Non-Small Cell [62]---Lung Adenocarcinoma [2]---Other [4]--Lung Cancer, Small Cell [8] Narrow your choices Trial phase: - Any -Pilot (small research study)Phase I (phase 1)Phase I/II (phases 1 and 2 combined)Phase II (phase 2)Phase II/III (phases 2 and 3 combined)Phase III (phase 3)Phase IV (phase 4)N/APhase III/IV (phases 3 and 4 combined)Phase 0 (very small research study) Reset 72 Clinical Trials found Expanded Access to Neladalkib (NVL-655) for People with Non-Small Cell Lung Cancer Researchers are assessing neladalkib for people with non-small cell lung cancer (NSCLC). The people in this study have NSCLC that has spread beyond its original location. In addition, their cancers have a fusion (genetic change) involving a gene called ALK. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau Expanded Access to Zidesamtinib for People with Advanced Solid Tumors Researchers are expanding access to the drug zidesamtinib for people with advanced solid tumors. The people in this study have non-small cell lung cancer (NSCLC) or another solid tumor with a fusion (change) in the ROS1 gene. This fusion can cause cancer cells to multiply and spread. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Next page Next ›